| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.38M | - | |
| Other | 218.9K | $5.15M | - | |
| Other | 167.1K | $3.93M | -10,259 | |
| CFO | 118.3K | $2.78M | - | |
| VP | 62.3K | $1.46M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2018 | Riker Lauren Bullaro76 | Vice President, Finance | Sale+OE | 1,000 | $54.35 | $54,350.00 | -8.7% | |
| Sep 24, 2018 | Riker Lauren Bullaro76 | Vice President, Finance | Sale+OE | 1,000 | $50.70 | $50,700.00 | -8.7% | |
| Aug 28, 2018 | Kronenfeld Mark A. | Director | Buy | 1,000 | $44.61 | $44,611.20 | +13.2% | |
| Aug 22, 2018 | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 1,667 | $44.48 | $74,148.16 | -13.7% | |
| Aug 15, 2018 | Stack David M67 | CEO And Chairman | Sale+OE | 33,062 | $47.32 | $1,564,431.94 | -14.5% | |
| Aug 14, 2018 | Williams Kristen Marie76 | CAO And General Counsel | Sell | 4,773 | $47.04 | $224,521.92 | -17.6% | |
| Jun 7, 2018 | Stack David M67 | CEO And Chairman | Sell | 18,406 | $36.28 | $667,764.48 | -6.6% | |
| Jun 4, 2018 | Hastings Paul J77 | Director | Sell | 771 | $33.90 | $26,136.90 | -21.9% | |
| Jun 4, 2018 | Williams Kristen Marie76 | CAO And General Counsel | Sell | 2,040 | $33.02 | $67,360.80 | -9.6% | |
| Jun 4, 2018 | Weiland Robert J. | Chief Commercial Officer | Sell | 373 | $33.02 | $12,316.46 | -6.8% |